The Enzime-linked Immunoabsorbent Assay (ELISA) is a straightforward diagnosis test that permits us to detect the presence of antibodies in the patient´s serum. STAB VIDA integrates a consortium that developed a novel lab-on-chip diagnostic tool to improve clinical diagnostic, disease monitoring and treatment of Lyme Disease. Being a multi-levelled disease caused by the bacterial complex Borrelia burgforferi sl and transmitted by ticks, Lyme Disease needs an immunological diagnosis that detects a global group of antigens.
Most of the current laboratory diagnostic methods lack sensitivity and specificity to detect early cases as well as late manifestations of the disease such as chronic or autoimmune-related infections.
Reaching the top of specificity and sensitivity.
Lyme Disease Diagnosis
At STAB VIDA we have developed an ELISA test for the diagnosis of Lyme disease.
Our ELISA test for Lyme Disease detects antigens throughout all levels of the disease, from early infection, to chronicle stage, providing important data for its diagnosis and treatment.
Contact us at: firstname.lastname@example.org | tel: +351 210438606 | skype ID: Sales from STAB